+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
All Genders
ID04886804

Beamion LUNG-1 Open Label Phase I Dose Escalation and Expansion Study of Zongertinib in Advanced or Metastatic Solid Tumors with HER2 Gene Changes

Led by Boehringer Ingelheim · Updated on 2026-10-28

554

Participants Needed

85

Research Sites

78 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying zongertinib, a medicine given as tablets once or twice daily, in adults with advanced cancers that have changes in the HER2 gene, including non-small cell lung cancer with specific HER2 mutations. The study has two parts the first aims to find the highest safe dose of zongertinib, and the second tests whether this dose can shrink tumors. This is a phase 1, open-label trial with participants who have not responded to previous treatments. In the first part, patients receive increasing doses of zongertinib alone to determine the maximum tolerated dose. Once this dose is established, it is used in the second part to evaluate tumor response. Participants continue taking zongertinib as long as they tolerate it and benefit. The study includes several cohorts, some based in the USA, Japan, and China. During the study, doctors regularly check patients health, monitor tumors using criteria like RECIST 1.1 and RANO-BM for brain metastases, and record any side effects possibly caused by zongertinib. The study measures outcomes such as maximum tolerated dose, dose-limiting toxicities, tumor response, disease control, progression-free survival, quality of life, and overall survival over up to 12 months. Participants remain in the trial as long as treatment is beneficial and tolerable.

CONDITIONS

Brief Title

Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

Research Team

B

Boehringer Ingelheim

A

Additional US locations available on demand. Please contact for options.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here